Phase III Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis

​ Conditions: Atopic Dermatitis

Interventions: Drug: VC005; Drug: VC005 Placebo

Sponsors: Jiangsu vcare pharmaceutical technology co., LTD

Not yet recruiting Conditions: Atopic Dermatitis
Interventions: Drug: VC005; Drug: VC005 Placebo
Sponsors: Jiangsu vcare pharmaceutical technology co., LTD
Not yet recruiting